ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
100.87
+2.84 (2.90%)
At close: Jun 11, 2026, 4:00 PM EDT
100.87
0.00 (0.00%)
After-hours: Jun 11, 2026, 4:10 PM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 80 employees as of March 31, 2026. The number of employees increased by 11 or 15.94% since the number was last reported on December 31, 2025.
Employees
80
Change
11
Growth
15.94%
Revenue / Employee
$70,910
Profits / Employee
-$4,787,847
Market Cap
7.82B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 80 | 11 | 15.94% | 80 | 0 |
| Dec 31, 2025 | 69 | 0 | - | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Corcept Therapeutics | 730 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Immunovant | 315 |
ABVX News
- 4 hours ago - ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 1 day ago - ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 2 days ago - ABVX DEADLINE: The Gross Law Firm Reminds ABIVAX Societe Anonyme Investors of Upcoming Securities Class Action Deadline - PRNewsWire
- 2 days ago - Abivax (ABVX) Faces Securities Fraud Investigation Amid Clinical Trial Concerns - GuruFocus
- 3 days ago - ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 7 days ago - Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against ABIVAX Societe Anonyme (ABVX) - Newsfile Corp
- 7 days ago - Spyre Therapeutics price target raised to $115 from $102 at Deutsche Bank - TheFly
- 7 days ago - Top Biotech Gainers: ABVX, CING, DRTS, MMED... - Nasdaq